In order to establish whether the therapeutic effects of targeting PGK1 in zebrafish models of ALS could be extended into the mammalian neuromuscular system, we next turned to a TDP-43 mouse model of ALS. The gene discussed is PGK1; the disease is amyotrophic lateral sclerosis.